CXSL1100079 | 聚乙二醇化重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2012-02-02 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2014-05-16 | view |
CXSR1700002 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products | State Standards | 2017-05-03 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-09-05 | view |
CXSR1700003 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products | State Standards | 2017-05-03 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-09-05 | view |
CXSL1300096 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2014-04-11 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
CXSL1300097 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2014-04-11 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |